Welcome to Ligand Pharmaceuticals

Ligand is a high-growth company with economic rights to some of the world's most important medicines.

Portfolio
Technologies
Licensing Opportunities

Latest News

Ligand Reports Third Quarter 2021 Financial Results

Read More

Ligand Pursuing Plans for OmniAb to Become a Standalone Public Company

Read More

Ligand to Report Third Quarter Financial Results on November 9, 2021

Read More

Recent Events

Stock Snapshot

LGND
Nasdaq
Volume
Market Cap
Day Range
52-Week Range